Healthcare · Diagnostics & Research

Dr. Lal Path Labs Ltd.

LALPATHLAB

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

NSE: LALPATHLABOfficial website ↗

Key metrics

Market Cap

₹23,455 cr

P/E Ratio

44.44x

P/B Ratio

10.8x

ROE

22.42%

ROCE

27.77%

Debt / Equity

0.07x

Net Margin

19.79%

Dividend Yield

93%

EPS

₹29.2

Period

FY2025

Shareholding pattern

As of Latest

Promoter: 54.91%FII: 31.55%Public: 13.54%

Deep-dive pages

10-Year Financials→Shareholding Pattern→Dividends & Corporate Actions→

Educational content — not investment adviceThis page presents publicly available information about Dr. Lal Path Labs Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.